ABP-450

DRUG4 trials

Sponsors

AEON Biopharma, Inc.

Conditions

Cervical DystoniaMigraine

Phase 2

Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

CompletedNCT04845178

AEON Biopharma, Inc.Migraine

Start: 2021-03-01End: 2024-08-06Updated: 2024-09-04

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

CompletedNCT04849988

AEON Biopharma, Inc.Cervical Dystonia

Start: 2021-03-29End: 2022-07-11Updated: 2024-02-14

Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia

CompletedNCT04871451

AEON Biopharma, Inc.Cervical Dystonia

Start: 2021-07-27End: 2023-07-24Updated: 2024-08-22

Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention

TerminatedNCT05016661

AEON Biopharma, Inc.Migraine

Start: 2021-10-19End: 2024-08-30Updated: 2024-09-20